Do Aspirin and Flavonoids Prevent Cancer through a Common Mechanism Involving Hydroxybenzoic Acids?—The Metabolite Hypothesis

por Sankaranarayanan, Ranjini, Kumar, D. Ramesh, Patel, Janki, Bhat, G. Jayarama
Publicado 2020

Mechanisms of Colorectal Cancer Prevention by Aspirin—A Literature Review and Perspective on the Role of COX-Dependent and -Independent Pathways

por Sankaranarayanan, Ranjini, Kumar, D. Ramesh, Altinoz, Meric A., Bhat, G. Jayarama
Publicado 2020

Aspirin inhibits glucose-6-phosphate dehydrogenase activity in HCT 116 cells through acetylation: Identification of aspirin-acetylated sites

por Ai, Guoqiang, Dachineni, Rakesh, Kumar, D. Ramesh, Alfonso, Lloyd F., Marimuthu, Srinivasan, Bhat, G. Jayarama
Publicado 2016

Aspirin metabolites 2,3-DHBA and 2,5-DHBA inhibit cancer cell growth: Implications in colorectal cancer prevention

por Sankaranarayanan, Ranjini, Valiveti, Chaitanya K., Dachineni, Rakesh, Kumar, D. Ramesh, Lick, Tana, Bhat, G. Jayarama
Publicado 2020

Salicylic acid metabolites and derivatives inhibit CDK activity: Novel insights into aspirin's chemopreventive effects against colorectal cancer

por Dachineni, Rakesh, Kumar, D. Ramesh, Callegari, Eduardo, Kesharwani, Siddharth S., Sankaranarayanan, Ranjini, Seefeldt, Teresa, Tummala, Hemachand, Bhat, G. Jayarama
Publicado 2017

The Flavonoid Metabolite 2,4,6-Trihydroxybenzoic Acid Is a CDK Inhibitor and an Anti-Proliferative Agent: A Potential Role in Cancer Prevention

por Sankaranarayanan, Ranjini, Valiveti, Chaitanya K., Kumar, D. Ramesh, Van slambrouck, Severine, Kesharwani, Siddharth S., Seefeldt, Teresa, Scaria, Joy, Tummala, Hemachand, Bhat, G. Jayarama
Publicado 2019